---
title: An FDA Panel Votes in September on a Blood Test That Screens for Many Cancers at Once
description: An FDA advisory panel votes on 23 September on Galleri, a blood test that screens for many cancers at once. Comments sent by 8 September reach the committee.
author: Dr Marina Nani (Editor-in-Chief)
date: 2026-08-09T08:30:00.000Z
updated: 2026-08-09T08:47:20.837Z
canonical: https://richhealthmagazine.com/article/fda-panel-galleri-multi-cancer-blood-test-vote
image: https://cdn.nanimediahouse.com/galleri-blood-test-laboratory-118886.webp
categories: Longevity & Science
content_type: News
region: United States
publication: Rich Health Magazine
access: members
schema_type: Article
---

A blood test meant to catch many cancers at once, rather than one at a time, goes in front of an outside expert panel next month. The Food and Drug Administration's Molecular and Clinical Genetics Panel meets on 23 September, from 9 a.m. to 6 p.m. Eastern time, to [discuss and vote on the premarket approval application](https://www.federalregister.gov/documents/2026/08/10/2026-16245/molecular-and-clinical-genetics-panel-of-the-medical-devices-advisory-committee-notice-of-meeting) for Galleri, the test made by GRAIL. The meeting is open to the public, at the FDA's White Oak campus in Silver Spring, Maryland, and it streams online.

GRAIL submitted the application on 29 January 2026. The FDA designated Galleri a Breakthrough Device in 2018.

## The Proposed Use Covers Adults Aged 50 and Older, Alongside Existing Screening

---

*This article is only available to registered readers. Visit the article URL to read the full piece.*